145.66MMarket Cap-1106P/E (TTM)
5.7000High5.5900Low6.25KVolume5.6900Open5.7000Pre Close35.44KTurnover0.03%Turnover RatioLossP/E (Static)25.96MShares14.748052wk High1.51P/B131.73MFloat Cap3.888052wk Low--Dividend TTM23.48MShs Float2352.0000Historical High--Div YieldTTM1.93%Amplitude3.8880Historical Low5.6710Avg Price1Lot Size
Inovio Pharmaceuticals Stock Forum
On Friday, the fear of human-to-human spread grew ever so slightly: The CDC confirmed that four health-care workers in Missouri had fallen sick after caring for a patient who was infected with bird flu.
https://www.msn.com/en-us/health/other/bird-flu-pandemic-fears-skyrocket-as-us-identifies-first-cases-of-possible-human-to-human-transmission/ar-AA1rwhf5?ocid=BingNewsSerp
Inovio Receives Advanced Therapy Medicinal Product Certificate From European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate Ino-3107
• BLA submission on track for INO-3107 in second half of 2024; if approved under accelerated approval pathway, could be first non-surgicaltreatment for recurrent respiratory papillomatosis (RRP)
• Planning initiation of confirmatory trial for INO-3107 based on FDA feedback
• Advancing plans for Phase 3 trial of INO-3112 in combination with LOQTORZITM ...
No comment yet